A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
Publication|Articles|September 17, 2026
Pharmacy Practice in Focus: Health Systems
- September 2026
- Volume 15
- Issue 5
Biologic Stewardship: The Next Frontier for Health System Pharmacists
Fact checked by: Ron Panarotti
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Advertisement
Advertisement
Biologic therapies rank among the most costly, highest-risk, and rapidly expanding medications in health care systems; however, numerous institutions lack a formal infrastructure for biologic stewardship. Pharmacists are uniquely positioned to lead safe, cost-effective, and evidence-based management of biologics.
Related to this article
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.
Before lung cancer therapy begins, diagnostic findings and treatment readiness shape care, creating opportunities for pharmacists to help patients start safely.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Advertisement
Advertisement